It is worth noting that the tumor inhibitory effect of SKP2 deletion on immunodeficient mice is weaker than that of immunocompetent mice, indicating that its antitumor effect is highly dependent on the reshaping of the immune microenvironment. Here, SKP2 is linked to neoplasm.